OTC Healthcare in Egypt to 2014

Product Code DAT21273
Publication Date July 2010
Publisher Datamonitor
Product Type Report
Pages 170
ISBN Number not applicable
Change currency
PDF £315.00 €379 $498 BUY >
PRINT £375 €452 $593 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

OTC Healthcare in Egypt to 2014

Introduction

This databook provides key data and information on the OTC healthcare market in Egypt. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.

Scope

  • Contains information on: analgesics, medicated skin product, topical OTC, traditional, indigestion, cough & cold, plasters & Bandages, vitamins and first aid kits
  • Market,category and segment level information on value with historic (2004-09) and forecast (2010-14) data
  • Category level company and brand share as well as distribution share information for 2008 and 2009
  • Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description

Highlights

The market for OTC healthcare in Egypt increased at a compound annual growth rate of 8% between 2004 and 2009.

The analgesics category led the OTC healthcare market in Egypt, accounting for a share of 23.6%.

Leading players in Egyptian OTC healthcare market include GlaxoSmithKline Plc, Johnson & Johnson and Amoun Pharmaceuticals Co.

Reasons to Purchase

  • Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Egypt
  • Design effective marketing and sales strategies by identifying key market categories and segments
  • Identify key players within the market to plan lucrative M&A, partnerships and agreements

Contents

  • Chapter 1 Executive Summary
    • Summary market level: OTC healthcare
    • Summary category level: analgesics
    • Summary category level: topical OTC medicines
    • Summary category level: cough and cold preparations
    • Summary category level: indigestion preparations
    • Summary category level: medicated skin products
    • Summary category level: first aid kits
    • Summary category level: other OTC healthcare products
    • Summary category level: plasters & bandages
    • Summary category level: traditional medicines
    • Summary category level: vitamins and minerals
  • Chapter 2 Introduction
    • What is this report about?
    • How to use this report
    • Market definition
  • Chapter 3 Market Overview
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 4 Leading Company Profiles
    • GlaxoSmithKline Plc
    • Johnson & Johnson
  • Chapter 5 Category Analysis: Analgesics
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 6 Category Analysis: Topical Otc Medicines
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 7 Category Analysis: Cough and Cold Preparations
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 8 Category Analysis: Indigestion Preparations
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 9 Category Analysis: Medicated Skin Products
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 10 Category Analysis: First Aid Kits
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 11 Category Analysis: Other Otc Healthcare Products
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 12 Category Analysis: Plasters & Bandages
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 13 Category Analysis: Traditional Medicines
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 14 Category Analysis: Vitamins and Minerals
    • Value analysis (Egyptian Pound), 2004-09
    • Value analysis (Egyptian Pound), 2009-14
    • Value analysis (US dollars), 2004-09
    • Value analysis (US dollars), 2009-14
    • Company and brand share analysis
    • Distribution analysis
  • Chapter 15 Country Comparison
    • Value
    • Market share
  • Chapter 16 New Product Development
    • Product launches over time
    • Recent product launches
  • Chapter 17 Macroeconomic Profile
    • Macroeconomic Indicators
  • Chapter 18 Research Methodology
    • Methodology overview
    • Secondary research
    • Market modeling
    • Creating an initial data model
    • Revising the initial data model
    • Creating a final estimate
    • Creating demographic value splits
    • Primary research
    • Data finalization
    • Ongoing research
  • Chapter 19 Appendix
    • Future readings
    • How to contact experts in your industry
    • Disclaimer
  • List of Figures
    • Figure 1: OTC healthcare, Egypt, value by category (EGPm), 2004-14
    • Figure 2: OTC healthcare, Egypt, category growth comparison, by value, 2004-14
    • Figure 3: OTC healthcare, Egypt, company share by value (%), 2008-09
    • Figure 4: OTC healthcare, Egypt, distribution channels by value (%), 2008-09
    • Figure 5: Analgesics, Egypt, value by segment (EGPm), 2004-14
    • Figure 6: Analgesics, Egypt, category growth comparison, by value, 2004-14
    • Figure 7: Analgesics, Egypt, company share by value (%), 2008-09
    • Figure 8: Analgesics, Egypt, distribution channels by value (%), 2008-09
    • Figure 9: Topical OTC medicines, Egypt, value by segment (EGPm), 2004-14
    • Figure 10: Topical OTC medicines, Egypt, category growth comparison, by value, 2004-14
    • Figure 11: Topical OTC medicines, Egypt, company share by value (%), 2008-09
    • Figure 12: Topical OTC medicines, Egypt, distribution channels by value (%), 2008-09
    • Figure 13: Cough and cold preparations, Egypt, value by segment (EGPm), 2004-14
    • Figure 14: Cough and cold preparations, Egypt, category growth comparison, by value, 2004-14
    • Figure 15: Cough and cold preparations, Egypt, company share by value (%), 2008-09
    • Figure 16: Cough and cold preparations, Egypt, distribution channels by value (%), 2008-09
    • Figure 17: Indigestion preparations, Egypt, value by segment (EGPm), 2004-14
    • Figure 18: Indigestion preparations, Egypt, category growth comparison, by value, 2004-14
    • Figure 19: Indigestion preparations, Egypt, company share by value (%), 2008-09
    • Figure 20: Indigestion preparations, Egypt, distribution channels by value (%), 2008-09
    • Figure 21: Medicated skin products, Egypt, value by segment (EGPm), 2004-14
    • Figure 22: Medicated skin products, Egypt, category growth comparison, by value, 2004-14
    • Figure 23: Medicated skin products, Egypt, company share by value (%), 2008-09
    • Figure 24: Medicated skin products, Egypt, distribution channels by value (%), 2008-09
    • Figure 25: First aid kits, Egypt, value (EGPm), 2004-14
    • Figure 26: First aid kits, Egypt, company share by value (%), 2008-09
    • Figure 27: First aid kits, Egypt, distribution channels by value (%), 2008-09
    • Figure 28: Other OTC healthcare products, Egypt, value by segment (EGPm), 2004-14
    • Figure 29: Other OTC healthcare products, Egypt, category growth comparison, by value, 2004-14
    • Figure 30: Other OTC healthcare products, Egypt, company share by value (%), 2008-09
    • Figure 31: Other OTC healthcare products, Egypt, distribution channels by value (%), 2008-09
    • Figure 32: Plasters & bandages, Egypt, value by segment (EGPm), 2004-14
    • Figure 33: Plasters & bandages, Egypt, category growth comparison, by value, 2004-14
    • Figure 34: Plasters & bandages, Egypt, company share by value (%), 2008-09
    • Figure 35: Plasters & bandages, Egypt, distribution channels by value (%), 2008-09
    • Figure 36: Traditional medicines, Egypt, value (EGPm), 2004-14
    • Figure 37: Traditional medicines, Egypt, company share by value (%), 2008-09
    • Figure 38: Traditional medicines, Egypt, distribution channels by value (%), 2008-09
    • Figure 39: Vitamins and minerals, Egypt, value by segment (EGPm), 2004-14
    • Figure 40: Vitamins and minerals, Egypt, category growth comparison, by value, 2004-14
    • Figure 41: Vitamins and minerals, Egypt, company share by value (%), 2008-09
    • Figure 42: Vitamins and minerals, Egypt, distribution channels by value (%), 2008-09
    • Figure 43: Global OTC healthcare market split (value terms, 2009), top five countries
    • Figure 44: Global OTC healthcare market value, 2004-09, top five countries
    • Figure 45: Annual data review process
  • List of Tables
    • Table 1: OTC healthcare category definitions
    • Table 2: OTC healthcare distribution channels
    • Table 3: OTC healthcare, Egypt, value by category (EGPm), 2004-09
    • Table 4: OTC healthcare, Egypt, value forecast by category (EGPm), 2009-14
    • Table 5: OTC healthcare, Egypt, value by category ($m), 2004-09
    • Table 6: OTC healthcare, Egypt, value forecast by category ($m), 2009-14
    • Table 7: OTC healthcare, Egypt, brand share by value (%), 2008-09
    • Table 8: OTC healthcare, Egypt, value by brand (EGPm), 2008-09
    • Table 9: OTC healthcare, Egypt, company share by value (%), 2008-09
    • Table 10: OTC healthcare, Egypt, value by company (EGPm), 2008-09
    • Table 11: OTC healthcare, Egypt, distribution channels by value (%), 2008-09
    • Table 12: OTC healthcare, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 13: GlaxoSmithKline Plc key facts
    • Table 14: Johnson & Johnson key facts
    • Table 15: Analgesics, Egypt, value by segment (EGPm), 2004-09
    • Table 16: Analgesics, Egypt, value forecast by segment (EGPm), 2009-14
    • Table 17: Analgesics, Egypt, value by segment ($m), 2004-09
    • Table 18: Analgesics, Egypt, value forecast by segment ($m), 2009-14
    • Table 19: Analgesics, Egypt, brand share by value (%), 2008-09
    • Table 20: Analgesics, Egypt, value by brand (EGPm), 2008-09
    • Table 21: Analgesics, Egypt, company share by value (%), 2008-09
    • Table 22: Analgesics, Egypt, value by company (EGPm), 2008-09
    • Table 23: Analgesics, Egypt, distribution channels by value (%), 2008-09
    • Table 24: Analgesics, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 25: Topical OTC medicines, Egypt, value by segment (EGPm), 2004-09
    • Table 26: Topical OTC medicines, Egypt, value forecast by segment (EGPm), 2009-14
    • Table 27: Topical OTC medicines, Egypt, value by segment ($m), 2004-09
    • Table 28: Topical OTC medicines, Egypt, value forecast by segment ($m), 2009-14
    • Table 29: Topical OTC medicines, Egypt, brand share by value (%), 2008-09
    • Table 30: Topical OTC medicines, Egypt, value by brand (EGPm), 2008-09
    • Table 31: Topical OTC medicines, Egypt, company share by value (%), 2008-09
    • Table 32: Topical OTC medicines, Egypt, value by company (EGPm), 2008-09
    • Table 33: Topical OTC medicines, Egypt, distribution channels by value (%), 2008-09
    • Table 34: Topical OTC medicines, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 35: Cough and cold preparations, Egypt, value by segment (EGPm), 2004-09
    • Table 36: Cough and cold preparations, Egypt, value forecast by segment (EGPm), 2009-14
    • Table 37: Cough and cold preparations, Egypt, value by segment ($m), 2004-09
    • Table 38: Cough and cold preparations, Egypt, value forecast by segment ($m), 2009-14
    • Table 39: Cough and cold preparations, Egypt, brand share by value (%), 2008-09
    • Table 40: Cough and cold preparations, Egypt, value by brand (EGPm), 2008-09
    • Table 41: Cough and cold preparations, Egypt, company share by value (%), 2008-09
    • Table 42: Cough and cold preparations, Egypt, value by company (EGPm), 2008-09
    • Table 43: Cough and cold preparations, Egypt, distribution channels by value (%), 2008-09
    • Table 44: Cough and cold preparations, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 45: Indigestion preparations, Egypt, value by segment (EGPm), 2004-09
    • Table 46: Indigestion preparations, Egypt, value forecast by segment (EGPm), 2009-14
    • Table 47: Indigestion preparations, Egypt, value by segment ($m), 2004-09
    • Table 48: Indigestion preparations, Egypt, value forecast by segment ($m), 2009-14
    • Table 49: Indigestion preparations, Egypt, brand share by value (%), 2008-09
    • Table 50: Indigestion preparations, Egypt, value by brand (EGPm), 2008-09
    • Table 51: Indigestion preparations, Egypt, company share by value (%), 2008-09
    • Table 52: Indigestion preparations, Egypt, value by company (EGPm), 2008-09
    • Table 53: Indigestion preparations, Egypt, distribution channels by value (%), 2008-09
    • Table 54: Indigestion preparations, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 55: Medicated skin products, Egypt, value by segment (EGPm), 2004-09
    • Table 56: Medicated skin products, Egypt, value forecast by segment (EGPm), 2009-14
    • Table 57: Medicated skin products, Egypt, value by segment ($m), 2004-09
    • Table 58: Medicated skin products, Egypt, value forecast by segment ($m), 2009-14
    • Table 59: Medicated skin products, Egypt, brand share by value (%), 2008-09
    • Table 60: Medicated skin products, Egypt, value by brand (EGPm), 2008-09
    • Table 61: Medicated skin products, Egypt, company share by value (%), 2008-09
    • Table 62: Medicated skin products, Egypt, value by company (EGPm), 2008-09
    • Table 63: Medicated skin products, Egypt, distribution channels by value (%), 2008-09
    • Table 64: Medicated skin products, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 65: First aid kits, Egypt, value (EGPm), 2004-09
    • Table 66: First aid kits, Egypt, value forecast (EGPm), 2009-14
    • Table 67: First aid kits, Egypt, value ($m), 2004-09
    • Table 68: First aid kits, Egypt, value forecast ($m), 2009-14
    • Table 69: First aid kits, Egypt, brand share by value (%), 2008-09
    • Table 70: First aid kits, Egypt, value by brand (EGPm), 2008-09
    • Table 71: First aid kits, Egypt, company share by value (%), 2008-09
    • Table 72: First aid kits, Egypt, value by company (EGPm), 2008-09
    • Table 73: First aid kits, Egypt, distribution channels by value (%), 2008-09
    • Table 74: First aid kits, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 75: Other OTC healthcare products, Egypt, value by segment (EGPm), 2004-09
    • Table 76: Other OTC healthcare products, Egypt, value forecast by segment (EGPm), 2009-14
    • Table 77: Other OTC healthcare products, Egypt, value by segment ($m), 2004-09
    • Table 78: Other OTC healthcare products, Egypt, value forecast by segment ($m), 2009-14
    • Table 79: Other OTC healthcare products, Egypt, brand share by value (%), 2008-09
    • Table 80: Other OTC healthcare products, Egypt, value by brand (EGPm), 2008-09
    • Table 81: Other OTC healthcare products, Egypt, company share by value (%), 2008-09
    • Table 82: Other OTC healthcare products, Egypt, value by company (EGPm), 2008-09
    • Table 83: Other OTC healthcare products, Egypt, distribution channels by value (%), 2008-09
    • Table 84: Other OTC healthcare products, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 85: Plasters & bandages, Egypt, value by segment (EGPm), 2004-09
    • Table 86: Plasters & bandages, Egypt, value forecast by segment (EGPm), 2009-14
    • Table 87: Plasters & bandages, Egypt, value by segment ($m), 2004-09
    • Table 88: Plasters & bandages, Egypt, value forecast by segment ($m), 2009-14
    • Table 89: Plasters & bandages, Egypt, brand share by value (%), 2008-09
    • Table 90: Plasters & bandages, Egypt, value by brand (EGPm), 2008-09
    • Table 91: Plasters & bandages, Egypt, company share by value (%), 2008-09
    • Table 92: Plasters & bandages, Egypt, value by company (EGPm), 2008-09
    • Table 93: Plasters & bandages, Egypt, distribution channels by value (%), 2008-09
    • Table 94: Plasters & bandages, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 95: Traditional medicines, Egypt, value (EGPm), 2004-09
    • Table 96: Traditional medicines, Egypt, value forecast (EGPm), 2009-14
    • Table 97: Traditional medicines, Egypt, value ($m), 2004-09
    • Table 98: Traditional medicines, Egypt, value forecast ($m), 2009-14
    • Table 99: Traditional medicines, Egypt, brand share by value (%), 2008-09
    • Table 100: Traditional medicines, Egypt, value by brand (EGPm), 2008-09
    • Table 101: Traditional medicines, Egypt, company share by value (%), 2008-09
    • Table 102: Traditional medicines, Egypt, value by company (EGPm), 2008-09
    • Table 103: Traditional medicines, Egypt, distribution channels by value (%), 2008-09
    • Table 104: Traditional medicines, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 105: Vitamins and minerals, Egypt, value by segment (EGPm), 2004-09
    • Table 106: Vitamins and minerals, Egypt, value forecast by segment (EGPm), 2009-14
    • Table 107: Vitamins and minerals, Egypt, value by segment ($m), 2004-09
    • Table 108: Vitamins and minerals, Egypt, value forecast by segment ($m), 2009-14
    • Table 109: Vitamins and minerals, Egypt, brand share by value (%), 2008-09
    • Table 110: Vitamins and minerals, Egypt, value by brand (EGPm), 2008-09
    • Table 111: Vitamins and minerals, Egypt, company share by value (%), 2008-09
    • Table 112: Vitamins and minerals, Egypt, value by company (EGPm), 2008-09
    • Table 113: Vitamins and minerals, Egypt, distribution channels by value (%), 2008-09
    • Table 114: Vitamins and minerals, Egypt, value by distribution channel (EGPm), 2008-09
    • Table 115: Global OTC healthcare market value, 2009
    • Table 116: Global OTC healthcare market split (value terms ($m), 2009), top five countries
    • Table 117: Leading players, top five countries
    • Table 118: Egypt OTC healthcare new product launches reports, by company 2009
    • Table 119: Egypt OTC healthcare new product launches SKUs, by company 2009
    • Table 120: Egypt OTC healthcare new product launches (reports), by flavor and fragrances 2009
    • Table 121: Egypt OTC healthcare new product launches (reports), by ingredients 2009
    • Table 122: Egypt OTC healthcare new product launches (reports), by package tags or claims 2009
    • Table 123: Egypt OTC healthcare new product launches - recent launches (2009)
    • Table 124: Egypt population, by age group, 2004-09 (millions)
    • Table 125: Egypt population forecast, by age group, 2009-14 (millions)
    • Table 126: Egypt population, by gender, 2004-09 (millions)
    • Table 127: Egypt population forecast, by gender, 2009-14 (millions)
    • Table 128: Egypt nominal GDP, 2004-09 (EGPbn, nominal prices)
    • Table 129: Egypt nominal GDP forecast, 2009-14 (EGPbn, nominal prices)
    • Table 130: Egypt real GDP, 2004-09 (EGPbn, 2000 prices)
    • Table 131: Egypt real GDP forecast, 2009-14 (EGPbn, 2000 prices)
    • Table 132: Egypt real GDP, 2004-09 ($bn, 2000 prices)
    • Table 133: Egypt real GDP forecast, 2009-14 ($bn, 2000 prices)
    • Table 134: Egypt consumer price index, 2004-09 (2000=100)
    • Table 135: Egypt consumer price index, 2009-14 (2000=100)